Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 391

Results For "EU"

5416 News Found

CPC Scientific announces new California peptide API manufacturing facility
News | June 24, 2022

CPC Scientific announces new California peptide API manufacturing facility

The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity


Merck KGaA doubles HPAPI production capacity in Wisconsin
News | June 24, 2022

Merck KGaA doubles HPAPI production capacity in Wisconsin

This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area


Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’  June 24
Digitisation | June 23, 2022

Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’ June 24

Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers


Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant
Drug Approval | June 23, 2022

Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant

Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients


Piramal Pharma Solutions appoints Herve Berdou as COO
People | June 23, 2022

Piramal Pharma Solutions appoints Herve Berdou as COO

Brings 25 years of global operations and supply chain experience to Piramal


Nippon Express launches new transport service using environmental-friendly isothermal packaging
Supply Chain | June 23, 2022

Nippon Express launches new transport service using environmental-friendly isothermal packaging

Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport


Merck presents positive results from phase 1/2 study evaluating V116
News | June 22, 2022

Merck presents positive results from phase 1/2 study evaluating V116

V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019


Sadhana Nitro Chem commences production of its 1st para aminophenol plant
News | June 22, 2022

Sadhana Nitro Chem commences production of its 1st para aminophenol plant

The company is now introducing the product into the India pharmaceutical market.


Merck appoints Chirfi Guindo as CMO for Merck Human Health
People | June 22, 2022

Merck appoints Chirfi Guindo as CMO for Merck Human Health

Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.


Briefs: Marksans Pharma and Alkem
News | June 22, 2022

Briefs: Marksans Pharma and Alkem

The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.